Jan–Dirk Studt
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 25
- Infectious Diseases top 1%
- Hematology top 2%
- Platelet Disorders and Treatments 22
- Neurology top 1%
- Nephrology top 2%
-
- Complement system in diseases 16
-
- Atrial Fibrillation Management and Outcomes 14
-
- Heparin-Induced Thrombocytopenia and Thrombosis 10
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 8
-
- COVID-19 and healthcare impacts 6
-
- Blood properties and coagulation 6
Jan–Dirk Studt
60 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Internal Medicine 651
- Infectious Diseases 1.3k
- Hematology 583
- Neurology 780
- Nephrology 286
Countries citing papers authored by Jan–Dirk Studt
This map shows the geographic impact of Jan–Dirk Studt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan–Dirk Studt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan–Dirk Studt more than expected).
Fields of papers citing papers by Jan–Dirk Studt
This network shows the impact of papers produced by Jan–Dirk Studt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan–Dirk Studt. The network helps show where Jan–Dirk Studt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan–Dirk Studt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 22 | |
| 9 | 2021 | 46 | |
| 10 | 2020 | 69 | |
| 11 | 2020 | 36 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 5 | |
| 14 | 2010 | 22 | |
| 15 | 2009 | 89 | |
| 16 | 2004 | 117 | |
| 17 | 2004 | 29 | |
| 18 | 2004 | 64 | |
| 19 | 2004 | 5 | |
| 20 | 2003 | 82 |
About Jan–Dirk Studt
Jan–Dirk Studt is a scholar working on Internal Medicine, Hematology, Immunology and Allergy, Genetics and Nephrology, having authored 65 papers that have together received 2.8k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (25 papers), Platelet Disorders and Treatments (22 papers), Complement system in diseases (16 papers), Atrial Fibrillation Management and Outcomes (14 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), COVID-19 and healthcare impacts (6 papers) and Blood properties and coagulation (6 papers). The work is most often cited by research in Internal Medicine (651 citations), Infectious Diseases (1.3k citations), Hematology (583 citations), Neurology (780 citations) and Nephrology (286 citations). Jan–Dirk Studt has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include G. Iapichino, Stefano Barco, Luca Carenzo, Nils Kucher, Paola Ferrazzi, Corrado Lodigiani, Maurizio Cecconi, Tim Sebastian, Maria Teresa Sandri and Clara Sacco. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Transfusion, Swiss Medical Weekly, British Journal of Haematology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.